Form4insider filings, from the source

SEC Form 4 · accession 0000921895-18-001208

Enveric Biosciences, Inc. · ENVB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Jeffrey E. Eberwein
Director · 10% Owner
Period of report
Mar 31, 2018
Accepted (ET)
Apr 4, 2018 · 8:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F3Mar 31, 2018J83,308$0.00D0IBy: Separately Managed Account
Common StockF1holding———47,164D
Common StockF1,F4holding———13,910IBy: Lone Star Value Co-Invest I, LP
Common StockF1,F5holding———2,972,592IBy: Lone Star Value Investors, LP
9.00% Series A Cumulative Preferred StockF1,F5holding———405,395IBy: Lone Star Value Investors, LP

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses